Swedish Orphan Financials

Swedish Orphan Stock Summary

Swedish Orphan competes with Zoetis, Takeda Pharmaceutical, Eisai, Shionogi, and Catalent. Swedish Orphan Biovitrum AB , an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, immunology, and genetic and metabolic diseases. Swedish Orphan Biovitrum AB is headquartered in Solna, Sweden. SWEDISH ORPHAN is traded on Frankfurt Stock Exchange in Germany.

Swedish Orphan Key Financial Ratios

There are many critical financial ratios that Swedish Orphan's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Swedish Orphan Biovitrum reports annually and quarterly.

Swedish Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Swedish Orphan's current stock value. Our valuation model uses many indicators to compare Swedish Orphan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Swedish Orphan competition to find correlations between indicators driving Swedish Orphan's intrinsic value. More Info.Swedish Orphan Biovitrum is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about  0.52  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Swedish Orphan Biovitrum is roughly  1.91 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Swedish Orphan's earnings, one of the primary drivers of an investment's value.

Swedish Orphan Biovitrum Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Swedish Orphan help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Swedish Orphan Biovitrum. We use our internally-developed statistical techniques to arrive at the intrinsic value of Swedish Orphan Biovitrum based on widely used predictive technical indicators. In general, we focus on analyzing Swedish Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Swedish Orphan's daily price indicators and compare them against related drivers.

When running Swedish Orphan's price analysis, check to measure Swedish Orphan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Swedish Orphan is operating at the current time. Most of Swedish Orphan's value examination focuses on studying past and present price action to predict the probability of Swedish Orphan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Swedish Orphan's price. Additionally, you may evaluate how the addition of Swedish Orphan to your portfolios can decrease your overall portfolio volatility.